Cargando…

Dietary recommendations for immunosuppressed patients of 17 hematopoietic stem cell transplantation centers in Brazil

INTRODUCTION: Low-microbial diets are recommended to reduce the risk of foodborne infections when hematopoietic stem cell transplantation patients have neutropenia. However there is no pattern concerning the composition of such a diet. OBJECTIVE: To collect information concerning the structure of nu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vicenski, Paola Pasini, Alberti, Paloma, do Amaral, Denise Johnsson Campos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459399/ https://www.ncbi.nlm.nih.gov/pubmed/23049398 http://dx.doi.org/10.5581/1516-8484.20120028

Ejemplares similares

Pre-sarcopenia and bone mineral density in adults submitted to hematopoietic stem cell transplantation
por: Pereira, Cristiane Pavan, et al.
Publicado: (2017)

Body composition of Fanconi anemia patients after hematopoietic stem cell transplantation
por: Silva, Priscilla Peixoto Policarpo da, et al.
Publicado: (2017)

Vitamin D deficiency in children and adolescents submitted to hematopoietic stem cell transplantation
por: Campos, Denise Johnsson, et al.
Publicado: (2014)

Nonadherence to immunosuppressives and treatment in kidney transplant: ADHERE BRAZIL Study
por: Marsicano-Souza, Elisa Oliveira, et al.
Publicado: (2021)

Immunosuppressive serum levels in allogeneic hematopoietic stem cell transplantation: pharmaceutical care contribution
por: CORRÊA, Paulo M., et al.
Publicado: (2016)

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Lycke, Jan, et al.
Publicado: (2020)

Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil
por: Paz, Alessandra, et al.
Publicado: (2018)

Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation
por: Wegener, D., et al.
Publicado: (2021)

The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
por: Ljungman, Per, et al.
Publicado: (2020)

Immunosuppression in kidney transplantation
por: MUNTEAN, ADRIANA, et al.
Publicado: (2013)

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
por: Majhail, Navneet Singh, et al.
Publicado: (2012)

Medical, ethical, and legal aspects of hematopoietic stem cell transplantation for Crohn’s disease in Brazil
por: Ruiz, Milton Artur, et al.
Publicado: (2020)

Telehealth in hematopoietic cell transplantation: perspective from patients at a public hospital in Brazil
por: Cordeiro, Ana, et al.
Publicado: (2022)

The immunosuppressive effect of the tick protein, Salp15, is long-lasting and persists in a murine model of hematopoietic transplant
por: Tomás-Cortázar, Julen, et al.
Publicado: (2017)

Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation
por: Drexler, Beatrice, et al.
Publicado: (2020)

Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients—High Efficacy of Rituximab
por: Gernert, Michael, et al.
Publicado: (2022)

P1334: THE IMPACT OF IMMUNOSUPPRESSION ON RECONSTITUTION OF CMV-SPECIFIC T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Dmitrova, A., et al.
Publicado: (2022)

Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
por: Ljungman, Per, et al.
Publicado: (2020)

Sixteen-Year Cohort of Liver Transplantation in the National Health System in Brazil: Analysis of Immunosuppression Maintenance Therapies
por: Nascimento, Guilherme Fagundes, et al.
Publicado: (2020)

Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents
por: Nabarrete, Juliana Moura, et al.
Publicado: (2021)

The role of basiliximab in the evolving renal transplantation immunosuppression protocol
por: Salis, Paola, et al.
Publicado: (2008)

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
por: Bowen, James D., et al.
Publicado: (2011)

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results
por: Koreth, John, et al.
Publicado: (2018)

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
por: Greco, Raffaella, et al.
Publicado: (2021)

Liver transplantation: immunosuppression and oncology
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2014)

Individualizing immunosuppression in lung transplantation
por: McDermott, Jennifer K., et al.
Publicado: (2018)

Update on Immunosuppression in Liver Transplantation
por: Tasdogan, Burcak E, et al.
Publicado: (2019)

Immunosuppressive strategies in lung transplantation
por: Chung, Paul A., et al.
Publicado: (2020)

Innovations in Immunosuppression for Intestinal Transplantation
por: Dogra, Harween, et al.
Publicado: (2022)

Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center
por: Chang, David H., et al.
Publicado: (2020)

Impact of Immunosuppression on the Metagenomic Composition of the Intestinal Microbiome: a Systems Biology Approach to Post-Transplant Diabetes
por: Bhat, M., et al.
Publicado: (2017)

First-Line Matched Related Donor Hematopoietic Stem Cell Transplantation Compared to Immunosuppressive Therapy in Acquired Severe Aplastic Anemia
por: Peinemann, Frank, et al.
Publicado: (2011)

Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend “when and for whom” in 2021?
por: Gagelmann, Nico, et al.
Publicado: (2021)

Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
por: Atalla, Angelo, et al.
Publicado: (2013)

Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation
por: Toapanta, Néstor, et al.
Publicado: (2022)

Interleukin-17 enhances immunosuppression by mesenchymal stem cells
por: Han, X, et al.
Publicado: (2014)

Dietary Patterns vs. Dietary Recommendations
por: De Cosmi, Valentina, et al.
Publicado: (2022)

Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group
por: Cillo, Umberto, et al.
Publicado: (2020)

Implications of social distancing in Brazil in the COVID-19 pandemic
por: Dantas, Raquel Cristina Cavalcanti, et al.
Publicado: (2022)

Transplant Center Characteristics And Survival After Allogeneic Hematopoietic Cell Transplantation In Adults
por: Majhail, Navneet S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0enltvjkju5dul61nnvba59kir